Patents by Inventor Ji Hyun Im

Ji Hyun Im has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250090605
    Abstract: A novel strain, Lactobacillus paracasei ATG-E1 (Accession No. KCTC 14245BP), and a composition containing the same for preventing or treating respiratory diseases which are caused by fine particulate matter. The Lactobacillus paracasei ATG-E1 strain reduces the number of immune cells bronchoalveolar and lung tissues and inhibits the expression of inflammatory cytokines such as interleukin-17A (IL-17A), tumor necrosis factor-? (TNF-?), macrophage inflammatory protein 2 (MIP2), C-X-C motif chemokine ligand 1 (CXCL-1), macrophage inflammatory protein-? (MIP-1?) or interleukin-6 (IL-6).
    Type: Application
    Filed: June 14, 2022
    Publication date: March 20, 2025
    Applicants: ATOGEN CO., LTD
    Inventors: Ji Hee KANG, Young Sil LEE, Dae Young LEE, Sung Hoon IM, II Yong JI, Gun Seok PARK, Seung Hyun KO, Juy I PARK, You Kyung LEE
  • Patent number: 8673945
    Abstract: The present invention relates to a solid pharmaceutical composition for preventing or treating cardiovascular disorders comprising amlodipine and losartan as active ingredients, and a disintegrant which is a mixture of at least two components selected from the group consisting of sodium starch glycolate, crosscarmellose sodium, and crosspovidone, which exhibits a high and stable level of amlodipine and losartan dissolution rates.
    Type: Grant
    Filed: December 28, 2009
    Date of Patent: March 18, 2014
    Assignee: Hanmi Science Co., Ltd
    Inventors: Jong Soo Woo, Jae Hyun Park, Young Il Kim, Kyeong Soo Kim, Ho Taek Yim, Ji Hyun Im
  • Patent number: 8673944
    Abstract: The present invention relates to a solid pharmaceutical composition for preventing or treating cardiovascular disorders comprising granular forms of amlodipine and losartan which are separated from each other, and a stabilizing agent, which has improved storage stability due to minimized interaction between amlodipine and losartan.
    Type: Grant
    Filed: June 5, 2009
    Date of Patent: March 18, 2014
    Assignee: Hanmi Science Co., Ltd
    Inventors: Jae Hyun Park, Kyeong Soo Kim, Ho Taek Yim, Ji Hyun Im
  • Publication number: 20110251245
    Abstract: The present invention relates to a solid pharmaceutical composition for preventing or treating cardiovascular disorders comprising amlodipine and losartan as active ingredients, and a disintegrant which is a mixture of at least two components selected from the group consisting of sodium starch glycolate, crosscarmellose sodium, and crosspovidone, which exhibits a high and stable level of amlodipine and losartan dissolution rates.
    Type: Application
    Filed: December 28, 2009
    Publication date: October 13, 2011
    Applicant: HANMI HOLDINGS CO., LTD.
    Inventors: Jong Soo Woo, Jae Hyun Park, Yong II Kim, Kyeong Soo Kim, Ho Taek Yim, Ji Hyun Im
  • Publication number: 20110245301
    Abstract: The present invention relates to a solid pharmaceutical composition for preventing or treating cardiovascular disorders comprising granular forms of amlodipine and losartan which are separated from each other, and a stabilizing agent, which has improved storage stability due to minimized interaction between amlodipine and losartan.
    Type: Application
    Filed: June 5, 2009
    Publication date: October 6, 2011
    Applicant: HANMI HOLDINGS CO., LTD.
    Inventors: Jae Hyun Park, Kyeong Soo Kim, Ho Taek Yim, Ji Hyun Im